What is the specific function of Trelagliptin?

Trelagliptin (Trelagliptin) is an oral DPP-4 inhibitor specifically used for blood sugar control in patients with type 2 diabetes . Its main mechanism of action is to inhibit dipeptidyl peptidase-4 (DPP-4) activity, prolong the half-life of GLP-1 and GIP, thereby enhancing postprandial insulin secretion by pancreatic beta cells, while inhibiting glucagon secretion and reducing hepatic gluconeogenesis. This effect not only improves postprandial hyperglycemia, but also helps maintain stable basal blood sugar levels and achieve all-day blood sugar management.

The use of trolagliptin is suitable for patients with type 2 diabetes, especially those who need long-term stable blood sugar control but want to reduce their daily drug burden. The characteristic of oral administration once a week makes it easier for patients to adhere to long-term treatment and improves compliance. Studies have shown that trotagliptin alone can significantly improve blood sugar control, and the effect is more ideal for patients who combine diet therapy and exercise therapy. In clinical practice, trotagliptin can be used in combination with other oral antidiabetic agents to achieve tighter glycemic control targets while maintaining the risk of hypoglycemia.

In addition, trotagliptin has been shown to be well tolerated in long-term use, with relatively mild side effects, mainly transient gastrointestinal discomfort or mild upper respiratory symptoms. Its hypoglycemia risk profile makes it a safe choice for older patients or those with risk factors for hypoglycemia. Through the scientific application of trotagliptin, patients can not only effectively control blood sugar, but also reduce the risk of complications and improve their quality of life during long-term treatment.

In short, tretagliptin has becomean important choice for the comprehensive management of type 2 diabetes due to its once-weekly administration, low side effects and stable blood sugar control, providing patients with a convenient and reliable long-term treatment plan.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin